✦ LIBER ✦

482 SAFETY OF QUTENZA™ (NGX-4010), A HIGH-CONCENTRATION CAPSAICIN PATCH IN PATIENTS WITH PERIPHERAL NEUROPATHIC PAIN AND DIABETES: RESULTS OF INTEGRATED ANALYSES

✍ Scribed by M. Backonja; G. Irving; D. Simpson; J. Tobias; G. Vanhove

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Safety of NGX-4010, a High-Con

✍ David M. Simpson; Suzanne Gazda; Stephen Brown; Lynn R. Webster; Shiao-Ping Lu; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 254 KB

490 QUTENZA™ (NGX-4010), A HIGH-CONCENTR

✍ G.A. Irving; M.M. Backonja; R. Rauck; J.K. Tobias; G.F. Vanhove 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 63 KB

Integrated analysis of efficacy and safe

✍ E. Blonsky; J. Tobias; M. Wallace; M. Backonja; R. Thakur; S. Lu; G. Vanhove 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Efficacy, safety, and tolerability of NG

✍ Lynn R. Webster; John F. Peppin; Frederick T. Murphy; Biao Lu; Jeffrey K. Tobias 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 460 KB

505 DURATION OF TREATMENT RESPONSE TO QU

✍ L. Webster; T.P. Malan; M.M. Tuchman; M.D. Mollen; J.K. Tobias; B. Lu; G.F. Vanh 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 48 KB

Changes in pain intensity and healthrela

✍ Persson, C.A.; Hansson, P.; Jensen, T.S.; Kvarstein, G.; Magnusson, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB